Login to Your Account

Complix inks its first big pharma partner deal with Merck for $280M

By Nuala Moran
Staff Writer

Wednesday, January 6, 2016

LONDON – Complix NV has reached a major inflexion point in the development of its alphabody technology, signing the first pharma partner in a deal with a headline value of $280 million.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription